5 Best Harvoni Alternatives For Hepatitis C Treatment

Hepatitis C is a life-threatening viral disease that infects the liver, chronic any cause for long-term adverse effects, including cirrhosis, liver cancer, or liver failure. Harvoni (ledipasvir and sofosbuvir) has been revolutionary for hepatitis C treatment, with a direct-acting antiviral (DAA) treatment protocol with a high cure rate for the vast majority of individuals. Many patients may need other treatment options for various reasons, including treatment failures, treatment intolerance, lack of access, etc. There are many other successful medications and regimens for hepatitis C management and cure.

Through this blog, we will highlight a handful of viable Harvoni alternatives with information on effectiveness, duration of treatment, and any side effects to ease treatment decision making.

 

Epclusa (Sofosbuvir and Velpatasvir)

Epclusa consists of sofosbuvir (an NS5B polymerase inhibitor) and velpatasvir (an NS5A inhibitor). Like Harvoni, Epclusa is a DAA regimen that targets the hepatitis C virus during its replicative phase.

Indication: Egclusa has been approved to treat all six genotypes of hepatitis C and therefore, it has a lot of versatility. It has shown solid efficacy in treatment-naïve and treatment-experienced patients.

Treatment Duration: Lasts 12 Weeks

Benefits:

• Wide Spectrum: Effective against all genotypes of hepatitis C.

• Well-Tolerated: In general, the treatment is well tolerated by most patients and has few side effects.

Drawbacks:

• While Epclusa is effective for most genotypes, high price can be an issue for the patient in some areas.

 

Mavyret (Glecaprevir and Pibrentasvir)

Mavyret contains two antiviral agents, glecaprevir (an NS3/4A protease inhibitor) and pibrentasvir (an NS5A inhibitor). They work differently on the hepatitis C virus's life cycle.

Indication: Mavyret is a very effective treatment for hepatitis C genotypes one through six. It can also be used for patients with varying degrees of liver disease, including cirrhosis.

Duration: Mavyret can take 8 weeks if the patient has never been treated and does not have cirrhosis. Most patients with cirrhosis or prior treatment experience will receive Mavyret for 12 weeks.

Pros:

• Reduced Duration of Treatment: The main benefit of Mavyret is the maximum length of treatment is 8 weeks for most patients.

• Can Treat All Genotypes: Mavyret can be used to treat all genotypes of the hepatitis C virus, making it a very versatile treatment option.

• Good Safety Profile: Overall, Mavyret does not usually result in many side effects.

Cons:

• Some mild side effects, like headache, fatigue, or nausea may occur.

 

Viekira Pak (Paritaprevir, Ritonavir, Ombitasvir, Dasabuvir)

Viekira Pak is a combination medicine that contains four drugs: paritaprevir, ritonavir (as a booster), ombitasvir, and dasabuvir. It may inhibit the hepatitis C virus at different stages of replication.

Indication: Viekira Pak is indicated for hepatitis C genotype 1, and it is often used in combination with other treatments for patients with more complicated hepatitis C disease.

Length of Treatment: Most patients take the medicine for 12 weeks.

Pros:

• Good Cure Rate for Genotype 1: The drug is effective against genotype 1 hepatitis C, the most common genotype of hepatitis C in the U.S.

• Combination of Four Agents: Viekira Pak allows patients to use four agents against their hepatitis C virus, and many patients have very good results with this combination, especially patients who have previously failed other treatment options.

Cons:

• Complex Regimen: The regimen can be more difficult than other treatments due to the multiple drugs.

Drug Interactions: Viekira Pak has significant drug interaction issues with certain medications, particularly some HIV medications, statins, and others.

 

Zepatier (Elbasvir and Grazoprevir)

Zepatier is a blend of elbasvir (an NS5A inhibitor) and grazoprevir (an NS3/4A protease inhibitor). It is known for its high efficacy, particularly among hepatitis C patients with genotype 1 or 4. 

Indication: Zepatier is required for genotypes 1 or 4, including those with cirrhosis. Zepatier is indicated for previously treated patients as well. 

Treatment Duration: Typically, Zepatier is used for a duration of 12 to 16 weeks, depending on cirrhosis status or treatment-naïve status.

Pros: 

• Good for Genotypes 1 and 4 - Zepatier is especially good for genotypes 1 and 4 which are not as common as other genotypes in the other treatment regimens. 

• Favorable Side Effect Profile - With rare exceptions, most patients experience mild side effects. 

Cons: 

• Limited Genotype Coverage - Zepatier is not universally effective for all genotypes, primarily because it does not treat genotype 3, a limitation of other treatments.

• Higher Cost - As with most DAAs, Zepatier may be expensive, but clinical costs and prices will vary among healthcare systems.

 

Vosevi (Sofosbuvir, Velpatasvir, and Voxilaprevir)

Vosevi consists of three direct-acting antivirals (DAAs) (sofosbuvir, velpatasvir, and voxilaprevir) indicated for the treatment of hepatitis C virus for individuals who have been previously treated with direct-acting antivirals. 

Indication: Vosevi is for patients who have previously failed DAA regimens, especially if the failure was due to resistance. 

Therapy duration: Vosevi therapy is generally 12 weeks. 

Pros: 

• Utilized for Treatment Failures: Vosevi is a good treatment option for patients who have not achieved sustained virologic response (SVR) due to previous DAA treatment.

• Broad Genotype Indication: This drug indicates all genotypes of hepatitis C virus. 

Cons: 

• Side Effects: Some patients may experience fatigue, headache, or diarrhea.

 

Final Words

When selecting a treatment for hepatitis C, several factors must be considered, including the specific genotype of the virus, whether the patient has cirrhosis, prior treatment history, and other health conditions. Although Harvoni remains a highly effective option, several alternatives like Epclusa, Mavyret, and Zepatier provide similar benefits with different advantages, such as shorter treatment durations, broader genotype coverage, and fewer side effects.

For patients who have failed previous treatments, options such as Vosevi offer hope for the eradication of the virus. As always, consult a healthcare professional to determine the best course of action based on your individual medical needs.

Get high-quality generic options for Hepatitis C from India at an affordable price. We offer worldwide delivery. Contact us now for more info.